Kunkel Lori Anne 4
4 · Enliven Therapeutics, Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-17$1.12/sh+15,958$17,873→ 30,712 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-17−15,958→ 3,741 totalExercise: $1.12Exp: 2030-06-15→ Common Stock (15,958 underlying)
Holdings
- 31,172(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The shares are held by Lori Kunkel Revocable Trust DTD 11/08/2018 Lori A Kunkel TTEE.
- [F2]All of the shares subject to this option are fully vested and exercisable as of the date hereof.